Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicaments for treating ischemic apoplexy sequela

A technology for ischemic stroke and sequelae, applied in the direction of drug combination, pharmaceutical formula, plant raw material, etc., can solve the problems of long course of treatment and low curative effect, and achieve the effect of improving muscle strength

Inactive Publication Date: 2008-09-17
GUANGZHOU UNIVERSITY OF CHINESE MEDICINE
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although these Chinese medicines and Chinese medicine compositions have certain curative effect in treating ischemic stroke sequelae, there are problems such as long course of treatment and low curative effect.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicaments for treating ischemic apoplexy sequela
  • Medicaments for treating ischemic apoplexy sequela

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] Embodiment 1 (granule):

[0054] Weigh 1800g of Guizhi, 1200g of notopterygium, 900g of Rhizoma Cyperi, 900g of Clematis, and 1200g of Scrophulariaceae, add water and decoct 3 times. After the first boil, fry with fire for 1.5 hours. Then combine the decoctions, filter and concentrate the filtrate at 80°C to a clear paste with a relative density of 1.25, put it in an oven at 75°C to dry the paste, and grind it into fine powder. Add appropriate amount of dextrin and starch to the obtained dry paste fine powder to 1000g, add water to make granules, then dry, granulate, and pack into 5.8g / bag (each contains about 3.5g of dry powder of medicine).

Embodiment 2

[0055] Embodiment 2 (granule)

[0056] Weigh 1250g of Guizhi, 750g of notopterygium, 500g of Rhizoma Cyperi, 500g of Clematis, and 500g of Scrophulariae, add water and boil for 3 times. After the first boil, fry with fire for 1.5 hours. Then combine the decoctions, filter and concentrate the filtrate at 80°C to a clear paste with a relative density of 1.25, put it in an oven at 75°C to dry the paste, and grind it into fine powder. Add appropriate amount of dextrin and starch to the obtained dry paste fine powder to 1000g, add water to make granules, then dry, granulate, and pack into 10g / bag (each contains about 3.5g of drug dry powder).

Embodiment 3

[0057] Embodiment 3 (granule)

[0058] Weigh 1250g of Guizhi, 750g of notopterygium, 625g of Rhizoma Cyperi, 625g of Clematis, and 625g of Scrophulariae, add water and decoct 3 times. After the first boil, fry with fire for 1.5 hours. Then combine the decoctions, filter and concentrate the filtrate at 80°C to a clear paste with a relative density of 1.25, put it in an oven at 75°C to dry the paste, and grind it into fine powder. Add appropriate amount of dextrin and starch to the obtained dry paste fine powder to 1000g, add water to make granules, then dry, granulate, and pack into 9g / bag (each contains about 3.5g of dry powder of medicine).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine for curing ischemic apoplexy sequela, the medicine is composed of an effective component and a pharmacy-acceptable excipient, wherein the effective component is made of active pharmaceutical ingredients with following weight percentages: cassia twig 25 to 50 percent, notopterygium root 15 to 30 percent, Nutgrass Galingale Rhizome 10 to 25 percent, Chinese clematis 10 to 25 percent and figwort root 10 to 25 percent. The invention can be eating preparations such as granules, capsules or tablets. The invention has the advantages of rapidly improving symptome and short course of treatment.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition prepared from raw materials of Chinese medicinal materials. Background technique [0002] Ischemic stroke is a common and frequently-occurring disease with high mortality, disability, and high mortality rate. Among the survivors, 70-80% of the patients are left with different degrees of disability. Sequelae of ischemic stroke refers to hemiplegia, aphasia, cognitive dysfunction and other symptoms left over after treatment and remission in the acute stage of cerebral infarction patients. It has the characteristics of long course of disease, low cure rate, and high recurrence rate, which seriously affects the quality of life of patients. , bringing a heavy burden to the family and society. At present, there is still a lack of effective drugs for the treatment of ischemic stroke sequelae. Relatively speaking, traditional Chines...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8905A61K9/16A61K9/20A61K9/48A61P9/10
Inventor 刘子志
Owner GUANGZHOU UNIVERSITY OF CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com